Make Sure Patients on Sublocade Have an Active Order in the EHR
Sublocade (SUB-loh-kayd) will be the first monthly buprenorphine injection for patients with opioid use disorder.
It's a subcutaneous depot injection given in the abdomen for patients stable on 8 to 24 mg/day of buccal or sublingual buprenorphine.
But it's different from Probuphine, the 6-month implant that's only for patients on up to 8 mg/day of buprenorphine.
Get unlimited access through an Enterprise license
Hospital Pharmacist's Letter includes:
- 12 issues every year, with brief articles about new meds and hot topics
- 300+ CE courses, including the popular CE-in-the-Letter
- Quick reference drug comparison charts
- Access to the entire archive
Already a subscriber? Log in
Not sold to individuals